Roivant Sciences Ltd. insider trades: Immunovant (IMVT) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Roivant Sciences Ltd. reports to the SEC
and 1 more company
Open-market buys and sales
25 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | IMVT | ↑ Buy | 16,666,666 | $21.00 | $350.0M | Direct | Dec 12, 2025 (0d) |
| Jan 13, 2025 | IMVT | ↑ Buy | 16,845,010 | $20.00 | $336.9M | Direct | Jan 15, 2025 (2d) |
| Oct 2, 2023 | IMVT | ↑ Buy | 1,526,316 | $38.00 | $58.0M | Direct | Oct 4, 2023 (2d) |
| Oct 6, 2022 | IMVT | ↑ Buy | 416,667 | $6.00 | $2.5M | Direct | Oct 7, 2022 (1d) |
| Sep 4, 2020 | IMVT | ↑ Buy | 380,000 | $33.00 | $12.5M | Direct | Sep 4, 2020 (0d) |
| Apr 16, 2020 | IMVT | ↑ Buy | 1,034,483 | $14.50 | $15.0M | Direct | Apr 17, 2020 (1d) |
| Feb 24, 2020 | AXGT | ↑ Buy | 5,333,333 | $3.75 | $20.0M | Direct | Feb 27, 2020 (3d) |
| Dec 17, 2019 | MYOV | ↑ Buy | 245,000 | $15.38 | $3.8M | Direct | Dec 18, 2019 (1d) |
| Dec 4, 2019 | MYOV | ↑ Buy | 254,193 | $18.03 | $4.6M | Direct | Dec 4, 2019 (0d) |
| Nov 25, 2019 | MYOV | ↑ Buy | 3,500,000 | $15.00 | $52.5M | Direct | Nov 27, 2019 (2d) |
| Nov 21, 2019 | MYOV | ↑ Buy | 243,812 | $12.39 | $3.0M | Direct | Nov 22, 2019 (1d) |
| Jun 19, 2019 | UROV | ↑ Buy10b5-1 | 18,204 | $8.32 | $151K | Direct | Jun 19, 2019 (0d) |
| Jun 14, 2019 | UROV | ↑ Buy10b5-1 | 22,011 | $8.06 | $177K | Direct | Jun 14, 2019 (0d) |
| Jun 11, 2019 | UROV | ↑ Buy10b5-1 | 21,338 | $8.31 | $177K | Direct | Jun 11, 2019 (0d) |
| Jun 6, 2019 | UROV | ↑ Buy10b5-1 | 21,122 | $7.86 | $166K | Direct | Jun 6, 2019 (0d) |
| Jun 4, 2019 | MYOV | ↑ Buy | 2,424,242 | $8.25 | $20.0M | Direct | Jun 6, 2019 (2d) |
| Jun 3, 2019 | UROV | ↑ Buy10b5-1 | 17,746 | $7.83 | $139K | Direct | Jun 3, 2019 (0d) |
| May 29, 2019 | UROV | ↑ Buy10b5-1 | 14,485 | $7.63 | $110K | Direct | May 29, 2019 (0d) |
| May 23, 2019 | UROV | ↑ Buy10b5-1 | 19,830 | $8.22 | $163K | Direct | May 23, 2019 (0d) |
| May 20, 2019 | UROV | ↑ Buy | 21,608 | $7.54 | $163K | Direct | May 20, 2019 (0d) |
| Mar 18, 2019 | AXON | ↑ Buy | 6,666,667 | $1.50 | $10.0M | Direct | Mar 19, 2019 (1d) |
| Dec 18, 2018 | AXON | ↑ Buy | 10,000,000 | $1.00 | $10.0M | Direct | Dec 20, 2018 (2d) |
| Oct 1, 2018 | UROV | ↑ Buy | 2,678,571 | $14.00 | $37.5M | Direct | Oct 3, 2018 (2d) |
| Jun 5, 2018 | AXON | ↑ Buy | 14,285,714 | $1.75 | $25.0M | Direct | Jun 7, 2018 (2d) |
| Apr 2, 2018 | MYOV | ↑ Buy | 1,110,015 | $20.27 | $22.5M | Direct | Apr 4, 2018 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other IMVT insiders
Open-market trades in the last 12 months
About Roivant Sciences Ltd.'s insider trades
Roivant Sciences Ltd. is an insider at Immunovant (IMVT). Since Apr 2, 2018, it has reported 25 open-market purchases worth $985.1M and no sales on SEC Form 4. In the last 12 months: 1 buy ($350.0M).
Its filings also include other transactions (6 filings), shares returned to the company (1 filing), grants and awards (1 filing), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IMVT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.